Mylan’s $12 billion takeover of Pfizer’s Upjohn unit has been cleared by the US authorities, but on the condition that the two companies divest various generic drug products. The Federal Trade ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback